Alcon Reports Strong First-Quarter 2024 Results Driven by Robust Sales in Contact Lenses and Ocular Health
Thursday, May 23 2024 | 16 h 20 min | News
Alcon reported its financial results for the three months ended March 31, 2024. For the first quarter of 2024, sales were $2.4 billion, an increase of 5% on a reported basis and 7% on a constant currency basis, as compared to the same quarter of the previous year. Alcon reported diluted earnings per share of $0.50 and core diluted earnings per share of $0.78 in the first quarter of 2024.
“Our first-quarter results reflect the outstanding work done by our more than 25,000 associates across both our Surgical and Vision Care franchises. We’re encouraged with the positive momentum we’re seeing across our broad range of products, particularly in our innovative contact lenses, where we saw record sales again this quarter.”
David J. Endicott, Alcon Chief Executive Officer
- First-quarter 2024 sales of $2.4 billion, up 5%, or 7% constant currency (cc)
- First-quarter 2024 diluted EPS of $0.50, up 43%, or 62% cc; core diluted EPS of $0.78 up 11%, or 21% cc
- First-quarter 2024 cash from operations of $341 million; free cash flow of $229 million, up $248 million year-over year
The full press release can be found HERE.
Want to see more like this article? Click here to subscribe to our FREE print magazines and e-newsletters!
